• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT TOTAL PSA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT TOTAL PSA Back to Search Results
Catalog Number 07K70-25
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/30/2019
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There was no further patient information provided by the customer.This report is being filed on an international product, list number 7k70 that has a similar product distributed in the us, list number 6c06.
 
Event Description
The customer reported falsely depressed architect total psa results on one patient.The results provide were: on (b)(6) 2019 sid (b)(6) initial = >100.00ng/ ml / retest = 0.799ng/ml / >100.000 / neat = 394.083 / diluted 1:4 = 98.996x4 = 395.984 / on (b)(6) 2019 retest neat = 378.445ng/ml.There was no reported impact to patient management.
 
Manufacturer Narrative
A review of tickets found only one additional complaint for lot 03330fn00 and no trends for the product for the complaint issue.Return testing was not completed as returns were not available.Historical performance of reagent lot 03330fn00 was evaluated using world wide data from abbottlink.The data determined that the patient median result for lot 03330fn00 is comparable to other lots in the field and confirms no systemic issue.This complaint ticket references service ticket (b)(4), initiated for erratic results obtained on the customers instrument.Through the service ticket, review of the instrument indicated the ph of the internal buffer solution was approximately ph8.The abbott customer service representative recommended replacement of the buffer solution and instrument flush after which the ph was determined to be approximately 7, suggesting contamination of the on-board buffer.The current complaint ticket documents that after the change of buffer solution, no further problems were identified.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the architect total psa reagent, lot 03330fn00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT TOTAL PSA
Type of Device
TOTAL PSA
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
diagnostics division
sligo NA
EI  NA
MDR Report Key9607283
MDR Text Key220245684
Report Number3008344661-2020-00004
Device Sequence Number1
Product Code LTJ
Combination Product (y/n)N
PMA/PMN Number
P910007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 02/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/18/2020
Device Catalogue Number07K70-25
Device Lot Number03330FN00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/31/2019
Initial Date FDA Received01/20/2020
Supplement Dates Manufacturer Received02/25/2020
Supplement Dates FDA Received02/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I1000SR ANALYZER, LN 01L86-01,; ARCHITECT I1000SR ANALYZER, LN 01L86-01,; SERIAL # (B)(4) ; SERIAL # (B)(4)
Patient Age84 YR
-
-